Euro vs US Dollar

Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.

Registrieren

RPHM Reneo Pharmaceuticals Inc

18,20

0,00 (0,00%)

29 Jan 2025 - Geschlossen

Verzögert um 15 Minuten

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

null

Reneo Pharmaceuticals (NASDAQ:RPHM)
Historical Stock Chart
Von Dez 2024 bis Jan 2025

Click Here for more Reneo Pharmaceuticals Charts.

Reneo Pharmaceuticals (NASDAQ:RPHM)
Historical Stock Chart
Von Jan 2024 bis Jan 2025

Click Here for more Reneo Pharmaceuticals Charts.

News Reneo Pharmaceuticals Inc

Form 4 - Statement of changes in beneficial ownership of securities
Donnerstag 30 Januar 2025 (5 Stunden vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Donnerstag 30 Januar 2025 (5 Stunden vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Donnerstag 30 Januar 2025 (5 Stunden vor) • Edgar (US Regulatory)

Form 424B3 - Prospectus [Rule 424(b)(3)]
Dienstag 10 Dezember 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Dienstag 10 Dezember 2024 (2 Monate vor) • Edgar (US Regulatory)

Form S-8 - Securities to be offered to employees in employee benefit plans
Montag 9 Dezember 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Donnerstag 7 November 2024 (3 Monate vor) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Donnerstag 7 November 2024 (3 Monate vor) • Edgar (US Regulatory)

Form 424B3 - Prospectus [Rule 424(b)(3)]
Donnerstag 31 Oktober 2024 (3 Monate vor) • Edgar (US Regulatory)

Form EFFECT - Notice of Effectiveness
Donnerstag 31 Oktober 2024 (3 Monate vor) • Edgar (US Regulatory)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Montag 28 Oktober 2024 (3 Monate vor) • Edgar (US Regulatory)

Form S-1 - General form for registration of securities under the Securities Act of 1933
Mittwoch 23 Oktober 2024 (3 Monate vor) • Edgar (US Regulatory)

Weitere Reneo Pharmaceuticals Inc News-Artikel

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen